A Prospective, Randomized Open-Label Study for Assessment of Antihypertensive Effect of Telmisartan Versus Cilnidipine Using Ambulatory Blood Pressure Monitoring (START ABPM Study)

BACKGROUND: The antihypertensive agent telmisartan is an angiotensin II receptor blocker with a terminal elimination half-life of 24 h and has a high lipophilicity, thereby enhancing its bioavailability. Another antihypertensive agent, cilnidipine is a calcium antagonist and has dual mode of action...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawant, Rahul, Suryawanshi, Sachin, Jadhav, Mayur, Barkate, Hanmant, Bhushan, Sumit, Rane, Tanmay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257498/
https://www.ncbi.nlm.nih.gov/pubmed/37304922
http://dx.doi.org/10.14740/cr1476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257498/
https://www.ncbi.nlm.nih.gov/pubmed/37304922
http://dx.doi.org/10.14740/cr1476

Ejemplares similares